Glucotrack, Inc. SEC filings GCTK
Glucotrack, Inc. has 495 filings in SEC EDGAR's recent list, going back to Dec 27, 2010. Its latest annual report, Form ARS, was filed on Jul 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| PRE 14A | Preliminary proxy statement | Oct 13, 2026 | Oct 13, 2026 |
| DEFA14A | Additional proxy material | Aug 21, 2026 | — |
| DEF 14A | Proxy statement | Aug 10, 2026 | Aug 10, 2026 |
| PRE 14A | Preliminary proxy statement | Jul 31, 2026 | Jul 31, 2026 |
| DEF 14A | Proxy statement | Jul 17, 2026 | Jul 17, 2026 |
| PRE 14A | Preliminary proxy statement | Jun 17, 2026 | Jun 17, 2026 |
| DEF 14A | Proxy statement | Feb 9, 2026 | Feb 9, 2026 |
| PRE 14A | Preliminary proxy statement | Jan 29, 2026 | Jan 29, 2026 |
| DEFA14A | Additional proxy material | Nov 7, 2025 | — |
| DEFA14A | Additional proxy material | Nov 3, 2025 | — |
| DEFA14A | Additional proxy material | Oct 31, 2025 | — |
| DEFA14A | Additional proxy material | Oct 28, 2025 | — |
| DEFA14A | Additional proxy material | Oct 15, 2025 | — |
| DEF 14A | Proxy statement | Oct 3, 2025 | Oct 3, 2025 |
| PRE 14A | Preliminary proxy statement | Sep 23, 2025 | Sep 23, 2025 |
| DEF 14A | Proxy statement | Apr 28, 2025 | Dec 31, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Dec 6, 2024 | Dec 6, 2024 |
| PRE 14A | Preliminary proxy statement | Nov 22, 2024 | Nov 22, 2024 |
| DEF 14A | Proxy statement | Aug 19, 2024 | Aug 19, 2024 |
| PRE 14A | Preliminary proxy statement | Aug 9, 2024 | Aug 9, 2024 |
| DEF 14A | Proxy statement | Apr 1, 2024 | Apr 1, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 22, 2024 | Mar 22, 2024 |
| DEF 14A | Proxy statement | Mar 2, 2023 | Mar 2, 2023 |
| DEF 14A | Proxy statement | Feb 26, 2020 | Feb 26, 2020 |
| PRE 14A | Preliminary proxy statement | Feb 11, 2020 | Feb 11, 2020 |
| DEF 14A | Proxy statement | Nov 23, 2018 | Nov 23, 2018 |
| PRE 14A | Preliminary proxy statement | Nov 13, 2018 | Nov 13, 2018 |
| DEFA14A | Additional proxy material | Mar 6, 2018 | — |
| DEF 14A | Proxy statement | Mar 1, 2018 | Mar 1, 2018 |
| DEFA14A | Additional proxy material | Jul 22, 2015 | — |
| DEFA14A | Additional proxy material | Jun 5, 2015 | — |
| DEFA14A | Additional proxy material | Jun 5, 2015 | — |
| DEF 14A | Proxy statement | Apr 30, 2015 | Apr 30, 2015 |
| DEFA14A | Additional proxy material | Jul 9, 2014 | — |
| DEFA14A | Additional proxy material | May 5, 2014 | — |
| DEF 14A | Proxy statement | Apr 30, 2014 | Apr 30, 2014 |
| DEF 14A | Proxy statement | Apr 30, 2013 | Apr 30, 2013 |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- GCTK (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rutherford, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1506983
- Former names
- Integrity Applications, Inc. (until Dec 9, 2021)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.